Targeted Hospital Market CDEX operates in the hospitals and healthcare sector with a lead product in medication safety and drug detection. Sales opportunities exist by targeting hospital networks, pharmacy departments, risk management and patient safety committees that mandate counterfeit detection and safe drug administration.

ValiMed Advantage ValiMed offers rapid validation of the right drug at the right dose without special training. This can be a compelling value proposition for hospital pharmacovigilance teams, sterile compounding areas, and inpatient pharmacies seeking to reduce adverse drug events and improve workflow efficiency.

Diversion and Counterfeit Focus The ID2 Methamphetamine Scanner and related drug diversion detection capabilities open upsell opportunities with law enforcement partnerships, correctional facilities, clinical security teams, and high-risk clinics concerned with substance misuse monitoring and facility security.

Growth via SMB Hospitals With a lean team and revenue in the lower mid-range, prioritize mid-sized hospitals and regional health systems that may be more agile in adopting new safety technologies and have dedicated budgets for medication safety and security solutions.

Strategic Partnerships There is potential to align with larger diagnostic and life science players through channel partnerships or OEM opportunities given the parallel markets of Bio-Rad, Thermo Fisher and Agilent. Joint programs could accelerate market reach and credibility in medication safety and detection segments.